Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell R Fisher

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Journal of Nanoscience and Nanotechnology|June 25, 2008
Apoferritin-templated yttrium phosphate nanoparticle conjugates for radioimmunotherapy of cancersHong Wu, Jun Wang, Zhemin Wang, et al.
Health Physics|July 15, 2022
Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical ExtravasationSean Wilson, Dustin Osborne, Misty Long, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 24, 2019
Melanoma-Targeting Property of Y-90-Labeled Lactam-Cyclized α-Melanocyte-Stimulating Hormone PeptideJingli Xu, Jianquan Yang, Rene Gonzalez, et al.
Health Physics|January 14, 2021
Patient-specific Extravasation Dosimetry Using Uptake Probe MeasurementsDustin Osborne, Jackson W Kiser, Josh Knowland, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 5, 2013
A non-aqueous reduction process for purifying ¹⁵³Gd produced in natural europium targetsAmanda M Johnsen, Chuck Z Soderquist, Bruce K McNamara, et al.
Molecular Pharmaceutics|February 15, 2019
Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma TargetingJianquan Yang, Jingli Xu, Lina Cheuy, et al.
Cancer Medicine|December 3, 2015
Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancerRebecca Phaeton, Zewei Jiang, Ekaterina Revskaya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse modelsYubin Miao, Nellie K Owen, Darrell R Fisher, et al.
Anticancer Research|August 5, 2006
First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agentThora J Jonasdottir, Darrell R Fisher, Jørgen Borrebaek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in miceGjermund Henriksen, Darrell R Fisher, John C Roeske, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Nanoscience and Nanotechnology|June 25, 2008
Apoferritin-templated yttrium phosphate nanoparticle conjugates for radioimmunotherapy of cancersHong Wu, Jun Wang, Zhemin Wang, et al.
Health Physics|July 15, 2022
Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical ExtravasationSean Wilson, Dustin Osborne, Misty Long, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 24, 2019
Melanoma-Targeting Property of Y-90-Labeled Lactam-Cyclized α-Melanocyte-Stimulating Hormone PeptideJingli Xu, Jianquan Yang, Rene Gonzalez, et al.
Health Physics|January 14, 2021
Patient-specific Extravasation Dosimetry Using Uptake Probe MeasurementsDustin Osborne, Jackson W Kiser, Josh Knowland, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 5, 2013
A non-aqueous reduction process for purifying ¹⁵³Gd produced in natural europium targetsAmanda M Johnsen, Chuck Z Soderquist, Bruce K McNamara, et al.
Molecular Pharmaceutics|February 15, 2019
Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma TargetingJianquan Yang, Jingli Xu, Lina Cheuy, et al.
Cancer Medicine|December 3, 2015
Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancerRebecca Phaeton, Zewei Jiang, Ekaterina Revskaya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse modelsYubin Miao, Nellie K Owen, Darrell R Fisher, et al.
Anticancer Research|August 5, 2006
First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agentThora J Jonasdottir, Darrell R Fisher, Jørgen Borrebaek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in miceGjermund Henriksen, Darrell R Fisher, John C Roeske, et al.
Pageof 9